New Delhi: European Medical Agency (EMA) said he had not received the application of the Covid-19 Vaccine Covine Covishield Maker Institute of India (SII) for authorization.
“For covid-19 covishield vaccines to be evaluated for use in the EU, developers need to submit the application of formal marketing authorization to EMA, which until now has not been received,” Ema said on the press direction.
Ema has approved the Comirnaty Pfizer Biontech, Spkevax, Vaxzevria and Johnson and Johnson’s Vaxssen Astrazeneca, Johnson and Johnson as a vaccine for Covid-19.
SII believes the approval of the European Medicine Agency (EMA) for the Covid-19 Covishield vaccine in a month, the CEO of the company Adar Poonawalla previously said.
Speaking in India Forum Global 2021, Poonawalla said, “It is not controversy, only that explodes beyond proportion and vaccine passport problems must be based on reciprocity of countries.” “EMA is really true in asking us to register, which we have through Astrazeneca, our partners, a month ago, and the process must take time.
Even Mhra England, who took time and we have applied for EMA.,” Poonawala added ,
There is no application received for EU authorization from Covishield, said the European Medicine Agency
